Author name: David Tuller

Trial By Error: The New Interferon “CFS” Study

By David Tuller, DrPH I haven’t had time to cover the new and wildly over-hyped study about prolonged fatigue–and purportedly about “chronic fatigue syndrome”–that was published this week in the journal Psychoneuroendocrinology. Thanks no doubt to the involvement of the Science Media Centre, this mildly interesting piece of research has received widespread media attention.

Trial By Error: And Cochrane Makes Another Move…

By David Tuller, DrPH Yet another interesting development has taken place at Cochrane, and this new development again suggests that things there might be moving in the right direction. On Friday, the organization withdrew a protocol for what is called an individual patient data (or IPD) review of exercise therapy for the illness it has …

Trial By Error: And Cochrane Makes Another Move… Read More »

Trial By Error: How BMJ Enabled Bristol’s Ethics Exemptions

By David Tuller, DrPH Earlier today, I sent the following e-mail to Dr Fiona Godlee, editorial director of BMJ. I cc’d Carol Monaghan MP, Darren Jones MP, and Nicky Morgan MP. I also cc’d Teresa Allen of the Health Research Authority. ********** Dear Dr. Godlee, As you know, I have spent some time criticizing a …

Trial By Error: How BMJ Enabled Bristol’s Ethics Exemptions Read More »

Trial By Error: Some Thoughts About NICE

By David Tuller, DrPH The UK’s National Institute for Health and Care Excellence (NICE), which develops clinical guidelines for a range of medical conditions, is currently selecting a committee to develop a new guidance for the illness it refers to as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The new guidance will replace one written in 2007, …

Trial By Error: Some Thoughts About NICE Read More »

Scroll to Top